Oxadiazolylindazole Sodium Channel Modulators are Neuroprotective toward Hippocampal Neurones

被引:58
作者
Clutterbuck, Lisa A. [1 ]
Posada, Cristina Garcia [1 ]
Visintin, Cristina [1 ]
Riddall, Dieter R. [1 ]
Lancaster, Barrie [1 ]
Gane, Paul J. [1 ]
Garthwaite, John [1 ]
Selwood, David L. [1 ]
机构
[1] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England
基金
英国惠康基金;
关键词
MULTIPLE-SCLEROSIS; NEUROPATHIC PAIN; NA+ CHANNELS; RAT-BRAIN; DEPENDENT INHIBITION; SPINAL-CORD; MECHANISMS; BLOCKERS; 1,2,4-OXADIAZOLES; LAMOTRIGINE;
D O I
10.1021/jm801180p
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report the discovery of a new class of neuroprotective voltage-dependent sodium channel modulators exemplified by (5-(1-benzyl-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl)methanamine. 11 (CFM1178). The compounds were inhibitors of [C-14]guanidinium ion flux in rat forebrain synaptosomes and displaced binding of the sodium channel ligand [H-3]BW202W92. 11 and the corresponding N-2-benzyl isomer, 38 (CFM6058), demonstrated neuroprotective activity in hippocampal slices comparable to sipatrigine. CYP450 enzyme inhibition observed with 11 was reduced with 38. In electrophysiological experiments on dissociated hippocampal neurons, these two compounds caused use- and voltage-dependent block of sodium currents. Sodium channel isoform profiling against Na(v)1.1-1.8 demonstrated that the standard sodium channel blocker lamotrigine had modest activity against Na(v)1.1, while sipatrigine was generally more potent and less selective. 11 and 38 showed potent activity against Na(v)1.6, pointing to pharmacological block of this isoform being consistent with the neuroprotective effect. 38 also showed use dependent block of Na(v)1.6 in HEK cells.
引用
收藏
页码:2694 / 2707
页数:14
相关论文
共 60 条
[31]  
LIN A, 2007, MOL OPERATING ENV
[32]   Distribution of the voltage gated sodium channel Nav 1.3-like immunoreactivity in the adult rat central nervous system [J].
Lindia, JA ;
Abbadie, C .
BRAIN RESEARCH, 2003, 960 (1-2) :132-141
[33]   Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat [J].
Lu, JJ ;
Crimin, K ;
Goodwin, JT ;
Crivori, P ;
Orrenius, C ;
Xing, L ;
Tandler, PJ ;
Vidmar, TJ ;
Amore, BM ;
Wilson, AGE ;
Stouten, PFW ;
Burton, PS .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (24) :6104-6107
[34]   Systemic lidocaine for neuropathic pain relief [J].
Mao, JR ;
Chen, LL .
PAIN, 2000, 87 (01) :7-17
[35]   Phase II clinical trial of sipatrigine (619C89) by continuous infusion in acute stroke [J].
Muir, KW ;
Holzapfel, L ;
Lees, KR .
CEREBROVASCULAR DISEASES, 2000, 10 (06) :431-436
[36]   Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice [J].
Nassar, Mohammed A. ;
Baker, Mark D. ;
Levato, Alessandra ;
Ingram, Rachel ;
Mallucci, Giovanna ;
McMahon, Stephen B. ;
Wood, John N. .
MOLECULAR PAIN, 2006, 2
[37]   The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions [J].
Obach, RS ;
Walsky, RL ;
Venkatakrishnan, K ;
Gaman, EA ;
Houston, JB ;
Tremaine, LM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (01) :336-348
[38]   [H-3] BATRACHOTOXININ A 20-ALPHA-BENZOATE BINDING TO SODIUM-CHANNELS IN RAT-BRAIN - CHARACTERIZATION AND PHARMACOLOGICAL SIGNIFICANCE [J].
PAUWELS, PJ ;
LEYSEN, JE ;
LADURON, PM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 124 (03) :291-298
[39]   Development of new antiepileptic drugs: challenges, incentives, and recent advances [J].
Perucca, Emilio ;
French, Cqueline ;
Bialer, Meir .
LANCET NEUROLOGY, 2007, 6 (09) :793-804
[40]   A novel drug binding site on voltage-gated sodium channels in rat brain [J].
Riddall, DR ;
Leach, MJ ;
Garthwaite, J .
MOLECULAR PHARMACOLOGY, 2006, 69 (01) :278-287